Good news today for generic drugmaker Mylan (NASDAQ:MYL). The company's share price popped more than 4%, after releasing a solid earnings report today. The year-over-year earnings per share this quarter were impressive, and revenue increased by 15%.
In the following video, health care analysts Max Macaluso and David Williamson dive into these results and discuss the key take-aways from this report.
David Williamson has no positions in the stocks mentioned above. Max Macaluso, Ph.D. has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.